[Function studies of an atropine derivative--ipratropium bromide in an aerosol device--in patients with chronic obstructive bronchopneumopathies].
Ipratropium exerted marked bronchodilating effects in 22 patients with chronic obstructive lung diseases. The tolerance of the drug was excellent. In long-term treatment the patients do not get accustomed to the drug.
D000336:Aerosols; D001286:Atropine Derivatives / Q000008:administration & dosage*; D002245:Carbon Dioxide; D005541:Forced Expiratory Volume; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D010100:Oxygen
D000336:Aerosols; D001286:Atropine Derivatives; D002245:Carbon Dioxide; D009241:Ipratropium; D010100:Oxygen
Etude fonctionnelle d'un dérivé atropinique--le bromure d'ipratropium en aérosol-doseur--chez des patients atteints de bronchopneumopathie obstructive chronique.